InVitro International, Inc. IVRO
OTC PK
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Revenue | 244.10K | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 244.10K | ||||
| Cost of Revenue | 44.10K | ||||
| Gross Profit | 200.00K | ||||
| SG&A Expenses | 174.30K | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 219.40K | ||||
| Operating Income | 24.70K | ||||
| Income Before Tax | 34.70K | ||||
| Income Tax Expenses | 800.00 | ||||
| Earnings from Continuing Operations | 33.90K | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 33.90K | ||||
| EBIT | 24.70K | ||||
| EBITDA | 25.60K | ||||
| EPS Basic | 0.00 | ||||
| Normalized Basic EPS | 0.00 | ||||
| EPS Diluted | 0.00 | ||||
| Normalized Diluted EPS | 0.00 | ||||
| Average Basic Shares Outstanding | 22.66M | ||||
| Average Diluted Shares Outstanding | 23.01M | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||